Repetitive transcranial magnetic stimulation as treatment for anxiety disorders.
Repetitive transcranial magnetic stimulation (rTMS) is a noninvasive and generally well-tolerated method of focally stimulating brain regions. It has been shown to be efficacious in the treatment for depression, but only to a limited degree. It has also been investigated for the treatment of some anxiety disorders, particularly obsessive-compulsive disorder, post-traumatic stress disorder and panic disorder. While anecdotal reports and open studies have suggested a therapeutic role for rTMS in anxiety disorders, controlled studies, which have varied greatly in terms of rTMS administration, have not shown it to be superior to placebo. Furthermore, reports in animal models of anxiety have not been consistent. Therefore, to date, there is no convincing evidence for the clinical role of rTMS in anxiety disorders. Further research is needed, drawing on advances in our understanding of pathological neurocircuitry in anxiety disorders and the mechanisms of action by which rTMS may alter that neurocircuitry. With advances in neuroimaging technology, this understanding is likely to be more accessible than it has been in the past.
Pigot
Melissa
M
School of Psychiatry, University of New South Wales, Black Dog Institute, Prince of Wales Hospital, Randwick, NSW 2031, Australia. m.pigot@unsw.edu.au
Loo
Colleen
C
Sachdev
Perminder
P
D000818:Animals; D001008:Anxiety Disorders / Q000453:epidemiology* / Q000628:therapy*; D002986:Clinical Trials as Topic / Q000639:trends*; D019317:Evidence-Based Medicine / Q000639:trends*; D006801:Humans; D015995:Prevalence; D050781:Transcranial Magnetic Stimulation / Q000379:methods* / Q000706:statistics & numerical data*; D016896:Treatment Outcome